New combo therapy aims to halt brain-spread lung cancer
NCT ID NCT07398599
First seen Feb 15, 2026 · Last updated May 03, 2026 · Updated 12 times
Summary
This study tests a stronger dose of a targeted cancer pill (EGFR-TKI) combined with two other drugs for people with advanced lung cancer that has spread to the lining of the brain and is no longer responding to standard treatment. About 30 adults will receive this combination to see if it can shrink the brain tumors and control the disease. The goal is to manage the cancer, not cure it, as ongoing treatment is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
Conditions
Explore the condition pages connected to this study.